Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Richards

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
British Journal of Haematology|July 26, 2002
Failure of a new protocol to improve treatment results in paediatric lymphoblastic leukaemia: lessons from the UK Medical Research Council trials UKALL X and UKALL XIJudith M Chessells, Georgina Harrison, Susan M Richards, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 29, 2004
Globotriaosylceramide isoform profiles in human plasma by liquid chromatography-tandem mass spectrometryBryant C Nelson, Thomas Roddy, Shaparak Araghi, et al.
Molecular Genetics and Metabolism|September 6, 2011
Atypical immunologic response in a patient with CRIM-negative Pompe diseaseMary-Alice Abbott, Sean N Prater, Suhrad G Banugaria, et al.
Clinical Chemistry|October 30, 2004
Liquid chromatography-tandem mass spectrometry quantification of globotriaosylceramide in plasma for long-term monitoring of Fabry patients treated with enzyme replacement therapyThomas P Roddy, Bryant C Nelson, Crystal C C Sung, et al.
Transplantation|July 23, 2009
In vivo characterization of rabbit anti-mouse thymocyte globulin: a surrogate for rabbit anti-human thymocyte globulinMelanie C Ruzek, Kathleen S Neff, Michael Luong, et al.
Pediatrics|October 7, 2004
Nephrotic syndrome complicating alpha-glucosidase replacement therapy for Pompe diseaseTracy E Hunley, Deyanira Corzo, Martha Dudek, et al.
Journal of Immunological Methods|February 20, 2007
Recommendations for the design, optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeuticsShalini Gupta, Stephen R Indelicato, Vijay Jethwa, et al.
Molecular Genetics and Metabolism|January 10, 2012
Anti-α-galactosidase A antibody response to agalsidase beta treatment: data from the Fabry RegistryWilliam R Wilcox, Gabor E Linthorst, Dominique P Germain, et al.
Blood|November 11, 2006
Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21)Anthony V Moorman, Susan M Richards, Hazel M Robinson, et al.
Blood|November 21, 2007
Characterization of in vitro antimurine thymocyte globulin-induced regulatory T cells that inhibit graft-versus-host disease in vivoMelanie C Ruzek, James S Waire, Deborah Hopkins, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|July 26, 2002
Failure of a new protocol to improve treatment results in paediatric lymphoblastic leukaemia: lessons from the UK Medical Research Council trials UKALL X and UKALL XIJudith M Chessells, Georgina Harrison, Susan M Richards, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 29, 2004
Globotriaosylceramide isoform profiles in human plasma by liquid chromatography-tandem mass spectrometryBryant C Nelson, Thomas Roddy, Shaparak Araghi, et al.
Molecular Genetics and Metabolism|September 6, 2011
Atypical immunologic response in a patient with CRIM-negative Pompe diseaseMary-Alice Abbott, Sean N Prater, Suhrad G Banugaria, et al.
Clinical Chemistry|October 30, 2004
Liquid chromatography-tandem mass spectrometry quantification of globotriaosylceramide in plasma for long-term monitoring of Fabry patients treated with enzyme replacement therapyThomas P Roddy, Bryant C Nelson, Crystal C C Sung, et al.
Transplantation|July 23, 2009
In vivo characterization of rabbit anti-mouse thymocyte globulin: a surrogate for rabbit anti-human thymocyte globulinMelanie C Ruzek, Kathleen S Neff, Michael Luong, et al.
Pediatrics|October 7, 2004
Nephrotic syndrome complicating alpha-glucosidase replacement therapy for Pompe diseaseTracy E Hunley, Deyanira Corzo, Martha Dudek, et al.
Journal of Immunological Methods|February 20, 2007
Recommendations for the design, optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeuticsShalini Gupta, Stephen R Indelicato, Vijay Jethwa, et al.
Molecular Genetics and Metabolism|January 10, 2012
Anti-α-galactosidase A antibody response to agalsidase beta treatment: data from the Fabry RegistryWilliam R Wilcox, Gabor E Linthorst, Dominique P Germain, et al.
Blood|November 11, 2006
Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21)Anthony V Moorman, Susan M Richards, Hazel M Robinson, et al.
Blood|November 21, 2007
Characterization of in vitro antimurine thymocyte globulin-induced regulatory T cells that inhibit graft-versus-host disease in vivoMelanie C Ruzek, James S Waire, Deborah Hopkins, et al.
Pageof 5